Edition:
United Kingdom

Rocket Pharmaceuticals Inc (RCKT.OQ)

RCKT.OQ on NASDAQ Stock Exchange Global Market

17.19USD
16 Feb 2018
Change (% chg)

$-0.42 (-2.39%)
Prev Close
$17.61
Open
$17.62
Day's High
$18.03
Day's Low
$16.75
Volume
71,086
Avg. Vol
67,159
52-wk High
$19.70
52-wk Low
$3.40

Chart for

About

Rocket Pharmaceuticals, Inc., formerly Inotek Pharmaceuticals Corporation, is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapies for glaucoma and other diseases of the eye. Its lead product candidate, trabodenoson, is a selective adenosine mimetic... (more)

Overall

Beta: --
Market Cap(Mil.): $70.77
Shares Outstanding(Mil.): 27.01
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 83.93 16.64
EPS (TTM): -- -- --
ROI: -- 1.66 10.66
ROE: -- 2.58 14.30

BRIEF-Rocket Pharmaceuticals Prices Public Offering Of Common Stock

* ROCKET PHARMACEUTICALS PRICES PUBLIC OFFERING OF COMMON STOCK

24 Jan 2018

BRIEF-Rocket Pharmaceuticals Announces Proposed Public Offering Of Common Stock

* ROCKET PHARMACEUTICALS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK

23 Jan 2018

BRIEF-Tang Capital Partners Reports 8.1 Pct Passive Stake In Rocket Pharmaceuticals - SEC Filing

* TANG CAPITAL PARTNERS REPORTS 8.1 PCT PASSIVE STAKE IN ROCKET PHARMACEUTICALS INC AS OF JAN 4 - SEC FILING Source text: (http://bit.ly/2ra05Is) Further company coverage:

16 Jan 2018

Rocket Internet CEO says ready to pounce with cash pile

BERLIN Germany's Rocket Internet needs to hold on to its mountain of cash so it can compete with rivals from the United States and China and pounce when investment opportunities arise, the chief executive said in an interview.

11 Jan 2018

INTERVIEW-Rocket Internet CEO says ready to pounce with cash pile

BERLIN, Jan 11 Germany's Rocket Internet needs to hold on to its mountain of cash so it can compete with rivals from the United States and China and pounce when investment opportunities arise, the chief executive said in an interview.

11 Jan 2018

Earnings vs. Estimates